About Jonathan Rosenfeld

Here are my most recent posts

Stryker May Still Be In Denial When It Comes To Their Financial Exposure Related To Recalled Hips

In a press release to shareholders, Stryker estimated that the recall of its Rejuvenate and ABG II modular-neck hip replacements would cost between $190 million and $390 million but Stryker might be a little too optimistic for comfort. Johnson and Johnson has already spent $800 million on a similar recall and still faces litigation in […]

MoM Hip Replacements and Heavy Metal Poisoning

Heavy Metal Poisoning From Metal Hips Remains A Legitimate Concern For Patients With Recalled Products As more information surfaces on the medical complications associated with popular metal-on-metal (MoM) hip replacement devices, heavy metal poisoning is now a concern facing many individuals. For some people with defective metal hips produced by manufactures such as DePuy, Stryker […]

Stryker Modular Stem Hip Recall Just Latest Chapter In Complications For Company

In February of 2003, Stryker received approval from the FDA to market its Trident Hip Replacement system, and its products were soon being used in numerous hip replacement surgeries across the country. Soon thereafter the company began to receive complaints about its hip replacements and failed to take any action to accommodate those who had […]